Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
A phase 3 trial of Fruquintinib, Sintilimab, Paclitaxel / nab-paclitaxel in endometrial cancer, run by Hutchmed, now recruiting.
Overview
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer is a phase 3 interventional study registered as NCT06584032 by Hutchmed, with 412 participants planned, started 2024-12-12 and due to reach its primary completion in 2029-01-08. Interventions recorded: fruquintinib, sintilimab, paclitaxel, doxorubicin. Conditions listed: Advanced Endometrial Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- PersonWeiguo Su
Shares Fruquintinib, Hutchmed.
- TrialSacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
Shares Doxorubicin, Paclitaxel / nab-paclitaxel, Endometrial cancer.
- TrialStudy of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Im
Shares Doxorubicin, Paclitaxel / nab-paclitaxel, Endometrial cancer.
- TrialPuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Shares Doxorubicin, Paclitaxel / nab-paclitaxel, Endometrial cancer.
- TrialA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Shares Doxorubicin, Paclitaxel / nab-paclitaxel, Endometrial cancer.
- TrialA Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Shares Doxorubicin, Endometrial cancer.
- TrialA Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
Shares Fruquintinib, Sintilimab.
- TrialA Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor